Metraipolis › archive › dc_4cffd32ee434

QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41800097
DOI
10.3389/fphar.2026.1748635
License (as archived)
solo-consultazione
Archived
2026-11-05T14:10:13.315Z
SHA-256 of the archived text
695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e
Stable URL of this page
https://metraipolis.com/documento/dc_4cffd32ee434

How to cite

QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097 — Europe PMC (en), https://europepmc.org/article/MED/41800097 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cffd32ee434 (Metraipolis archive dc_4cffd32ee434, sha256 695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e)
BibTeX
@misc{dc4cffd32ee434,
  title = {QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice — Europe PMC PMID:41800097},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800097},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cffd32ee434; sha256 695c5b5c6a91f9229a4747e815ade5239808f740da2efe098f4d380edbf86a5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800097. Agents can read the archived copy with the MCP tool read_document.